{"schema_version":"secwatch.filing_event.v1","accession":"0001654954-23-010856","form_type":"8-K","ticker":"VTAK","cik":"0001716621","company_name":"Catheter Precision, Inc.","filed_at":"2023-08-15T23:59:59+00:00","discovered_at":"2026-05-14T18:03:34.969125+00:00","generated_at":"2026-06-11T09:29:56.889409+00:00","sec_items":["2.02"],"event_type":"other_material","sentiment":"negative","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"Ra Medical Systems estimates Q2 2023 revenue of $96,000; H1 2023 revenue $181,000","bullets":["Preliminary Q2 2023 revenue estimate of approximately $96,000 (versus $0 prior year quarter, if applicable).","Six-month revenue estimate of approximately $181,000 for H1 2023.","Revenue figures are preliminary and subject to adjustment upon completion of the audit review.","Company filed a Form 12b-25 (NT 10-Q) indicating a delay in its quarterly report."],"urls":{"canonical":"https://secwatch.observer/filing/0001654954-23-010856","json":"https://secwatch.observer/filing/0001654954-23-010856.json","markdown":"https://secwatch.observer/filing/0001654954-23-010856.md","text":"https://secwatch.observer/filing/0001654954-23-010856.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1716621/000165495423010856/0001654954-23-010856-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1716621/000165495423010856/rmed_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-11T09:29:56.889409+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"4a9d4a4a1b1991075d3316ea43b9aeaf5e45bbc7","claim":"Catheter Precision, Inc. reported the six months ended June 30, 2023 results: revenue approximately $181,000.","evidence_excerpt":"On August 15, 2023, Ra Medical Systems, Inc. (the “Company”) filed a Form 12b-25 with the Securities and Exchange Commission that estimated that the Company will recognize revenues of approximately $96,000 for the quarter ended June 30, 2023 and approximately $181,000 for the six months ended June 30, 2023.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1716621/000165495423010856/0001654954-23-010856-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the six months ended June 30, 2023"},{"label":"Revenue","value":"approximately $181,000"},{"label":"Result","value":"preliminary results"}],"fact_type":"earnings_release"},{"claim_id":"e23d0f7ea79a98ec1ee43e978c50c43564afa25e","claim":"Catheter Precision, Inc. reported the quarter ended June 30, 2023 results: revenue approximately $96,000.","evidence_excerpt":"On August 15, 2023, Ra Medical Systems, Inc. (the “Company”) filed a Form 12b-25 with the Securities and Exchange Commission that estimated that the Company will recognize revenues of approximately $96,000 for the quarter ended June 30, 2023 and approximately $181,000 for the six months ended June 30, 2023.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1716621/000165495423010856/0001654954-23-010856-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the quarter ended June 30, 2023"},{"label":"Revenue","value":"approximately $96,000"},{"label":"Result","value":"preliminary results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}